Eco Science Financials
This page shows Eco Science (ESSI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
ESSI’s dominant visible mechanic is survival through external funding, with cash burn repeatedly backfilled instead of earned from operations.
In FY2026, operating cash outflow of-$320K was almost one-for-one offset by financing inflow of$321K . Because that pattern preserved only$1.7K of cash while liabilities sat at$16.9M , the reported cash balance reflects funding access rather than operating self-sufficiency, and the same pattern had already appeared in the prior year.
This is not meaningfully a margin story; with reported revenue absent in the latest valid periods, the useful lens is cash consumption versus funding access. R&D spending of
The balance-sheet deficit looks structural, not seasonal: across the last two years, liabilities increased by about
Financial Health Signals
Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Eco Science's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Eco Science's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Eco Science passes 2 of 9 financial strength tests. No profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
Key Financial Metrics
Earnings & Revenue
Eco Science generated $0 in revenue in fiscal year 2026.
Cash & Balance Sheet
Eco Science held $2K in cash against $0 in long-term debt as of fiscal year 2026.
Eco Science had 53M shares outstanding in fiscal year 2026. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
Eco Science invested $332K in research and development in fiscal year 2026. This represents a decrease of 18.1% from the prior year.
ESSI Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| Cost of Revenue | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| Gross Profit | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| R&D Expenses | $74K-7.3% | $80K-18.9% | $99K | N/A | $86K+4.9% | $82K-2.1% | $84K | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$226K+7.1% | -$243K+4.5% | -$254K | N/A | -$256K-11.3% | -$230K+16.7% | -$276K | N/A |
| Interest Expense | $10K0.0% | $10K+3.4% | $9K | N/A | $10K+12.1% | $9K-6.6% | $10K | N/A |
| Income Tax | $0 | N/A | $0 | N/A | $0 | N/A | $0 | N/A |
| Net Income | -$246K+6.5% | -$263K+3.9% | -$273K | N/A | -$275K-10.5% | -$249K+15.5% | -$295K | N/A |
| EPS (Diluted) | $0.00 | $0.00+100.0% | $-0.01 | N/A | $-0.01 | $0.00+100.0% | $-0.01 | N/A |
ESSI Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $102K-2.6% | $105K-0.1% | $105K-2.4% | $107K+3.0% | $104K-0.6% | $105K+3.1% | $102K-0.5% | $102K |
| Current Assets | $2K-58.2% | $5K-1.8% | $5K-35.8% | $7K+77.4% | $4K-13.6% | $5K+201.7% | $2K-25.3% | $2K |
| Cash & Equivalents | $2K-38.2% | $3K+82.3% | $2K-39.7% | $3K-31.3% | $4K-13.6% | $5K+201.7% | $2K-25.3% | $2K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $17.4M+1.4% | $17.2M+1.6% | $16.9M+1.6% | $16.7M+1.7% | $16.4M+1.7% | $16.1M+1.6% | $15.9M+1.9% | $15.6M |
| Current Liabilities | $17.4M+1.4% | $17.2M+1.6% | $16.9M+1.6% | $16.7M+1.7% | $16.4M+1.7% | $16.1M+1.6% | $15.9M+1.9% | $15.6M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$17.3M-1.4% | -$17.1M-1.6% | -$16.8M-1.7% | -$16.6M-1.7% | -$16.3M-1.7% | -$16.0M-1.6% | -$15.8M-1.9% | -$15.5M |
| Retained Earnings | -$79.5M-0.3% | -$79.3M-0.3% | -$79.0M-0.3% | -$78.7M-0.4% | -$78.4M-0.4% | -$78.2M-0.3% | -$77.9M-0.4% | -$77.6M |
ESSI Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$98K-7.2% | -$92K-30.2% | -$71K+32.6% | -$105K-37.8% | -$76K-35.4% | -$56K+32.2% | -$83K+25.8% | -$112K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | $0 | $0 | $0 | $0 | $0 | $0+100.0% | -$100K |
| Financing Cash Flow | $97K+4.3% | $93K+34.3% | $69K-32.9% | $104K+37.3% | $75K+27.1% | $59K-27.9% | $82K-61.0% | $211K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ESSI Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -241.2%+10.1pp | -251.3%+9.9pp | -261.2% | N/A | -264.5%-26.7pp | -237.8%+52.2pp | -290.1% | N/A |
| Current Ratio | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.00 |
| Debt-to-Equity | -1.010.0 | -1.010.0 | -1.010.0 | -1.010.0 | -1.010.0 | -1.010.0 | -1.010.0 | -1.01 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$16.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is Eco Science's annual revenue?
Eco Science (ESSI) reported $0 in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What is Eco Science's operating cash flow?
Eco Science (ESSI) generated -$320K in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Eco Science's total assets?
Eco Science (ESSI) had $105K in total assets as of fiscal year 2026, including both current and long-term assets.
How much does Eco Science spend on research and development?
Eco Science (ESSI) invested $332K in research and development during fiscal year 2026.
What is Eco Science's current ratio?
Eco Science (ESSI) had a current ratio of 0.00 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.
What is Eco Science's debt-to-equity ratio?
Eco Science (ESSI) had a debt-to-equity ratio of -1.01 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Eco Science's cash runway?
Based on fiscal year 2026 data, Eco Science (ESSI) had $2K in cash against an annual operating cash burn of $320K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Eco Science's debt-to-equity ratio negative or unusual?
Eco Science (ESSI) has negative shareholder equity of -$16.8M as of fiscal year 2026, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Eco Science's Piotroski F-Score?
Eco Science (ESSI) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
How financially healthy is Eco Science?
Eco Science (ESSI) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.